Skip to main content
Journal Article

Immunogenicity assessment of biotechnology-derived therapeutic proteins (EMEA/CHMP/BMWP/14327/2006)

  • EMA
Guideline (2008) (0) 18
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Guideline under revision. Draft guideline (24 Sep 2015) available (EMEA/CHMP/BMWP/14327/2006 Rev. 1) at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/10/WC500194507.pdf

Cite

CITATION STYLE

APA

EMA. (2008). Immunogenicity assessment of biotechnology-derived therapeutic proteins (EMEA/CHMP/BMWP/14327/2006). Guideline, (0), 18. Retrieved from http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000408.jsp

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free